No profile data available.
Generate Biomedicines, Inc. (GENB) is a listed company, based in Somerville, United States, with about 312 full-time employees.
It reported revenue of $31.89 million for fiscal year 2025, up 55.9% from fiscal year 2024, and net income of -$249.52 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $6.31 million, down 37.7% from a year before. Its market capitalization was $1.84 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development.
Generate Biomedicines reported $31.89 million in revenue for fiscal year 2025, up 55.9% from $20.46 million in fiscal year 2024. In Q2 2026 revenue was $6.31 million.
$1.84 billion as of October 9, 2026.